|
|
CASE REPORT |
|
Year : 2015 | Volume
: 17
| Issue : 2 | Page : 119-120 |
|
Serratia marcescens conjunctivitis due to nasolacrimal duct obstruction
Anna Cherian
Department of Microbiology, Regional Institute of Ophthalmology; Department of Microbiology, Government Medical College, Thiruvananthapuram, Kerala, India
Date of Web Publication | 15-Dec-2015 |
Correspondence Address: Anna Cherian Department of Microbiology, Regional Institute of Ophthalmology; Department of Microbiology, Government Medical College, Thiruvananthapuram, Kerala India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-1282.171896
A case of a 3-month-old child with conjunctivitis subsequent to nasolacrimal duct (NLD) obstruction is reported. Serratia marcescens (S. marcescens) was cultured from the discharge from the left eye; the child was treated and cured effectively with appropriate antibiotics. Keywords: Conjunctivitis, nasolacrimal duct (NLD), Serratia marcescens (S. marcescens)
How to cite this article: Cherian A. Serratia marcescens conjunctivitis due to nasolacrimal duct obstruction. J Acad Clin Microbiol 2015;17:119-20 |
Introduction | |  |
Serratia marcescens (S. marcescens) is a ubiquitous opportunistic nosocomial pathogen causing a variety of infections in all age groups including neonates with high mortality rates and is resistant to most of the conventional antibiotics. Outbreaks of S. marcescens meningitis, wound infections and arthritis have occurred in paediatric wards. [1]
In the eye, it may cause conjunctivitis, keratitis, endophthalmitis and tear duct infections. [2] Conjunctivitis develops in neonates because of their immature lacrimal duct systems, immature immune systems and because colonisation of the conjunctivae can occur during neonatal care. [3] All strains of S. marcescens are considered intrinsically resistant to Ampicillin, macrolides and first-generation Cephalosporins. Aminoglycosides have shown consistent efficacy in vitro. Fluoroquinolones, third-generation Cephalosporins, Trimethoprim/sulfamethoxazole, Tetracycline and synthetic penicillins show variable activity. [4]
Case report | |  |
This male baby born by lower segment caesarean section (LSCS) at term, in a private hospital, had discharge from both eyes from the third day of birth and was treated with tobramycin eye drops. At 35 days of birth, the child was diagnosed with urinary tract infection and was treated at two private hospitals and finally got admitted at Sree Avittom Thirunal Hospital (SATH), Medical College, Thiruvananthapuram, Kerala, India for further investigations and management. The child was then referred from SATH to the Regional Institute of Ophthalmology (RIO) for complaints of discharge and lacrimation of both eyes. On examination, the child had nasal block and congenital NLD obstruction. Ear, nose and throat (ENT) consultation showed no local cause for the obstruction.
Gram stain of discharge from the eyes showed plenty of pus cells and gram-negative bacilli. The child was given Ofloxacin eye drops with advice to come the following day for follow-up. Pus culture on blood agar (BA) showed pure growth of colonies that had a slight pink colour when viewed at an angle. MacConkey agar grew pale lactose-fermenting colonies. To further investigate the nature of the pigmentation noticed, sub cultures were done on nutrient agar the same day and kept at room temperature. The very next day these colonies developed a light orange-pink colour that on further incubation changed to dark orange-red colour. Direct sensitivity testing on Mueller-Hinton agar gave colourless colonies sensitive to Ciprofloxacin, Ofloxacin, Gatifloxacin, Gentamicin, Amikacin and third-generation Cephalosporins but resistant to Ampicillin.
The organism was a gram-negative bacillus that was catalase-positive, oxidase-negative, utilised citrate, Voges-Proskauer (VP)-test positive and reduced nitrate. Indole and Methyl-Red tests were negative. There was acid production from glucose, maltose and mannitol
The identity of the organism was confirmed as S. marcescens by Vitek 2 system (bioMérieux) at the State Public Health Laboratory, Thiruvananthapuram, Kerala, India.
According to the sensitivity report, the organism was sensitive to Ofloxacin, hence the eye drops were continued. The child gradually improved and a repeat culture of conjunctival swab after a week was sterile. Urine culture done at RIO was sterile as well.
Discussion | |  |
S. marcescens is a motile, facultative anaerobic gram-negative rod of the Enterobacteriaceae family that includes Escherichia coli and Salmonella as well. Serratia is well-known for its production of a reddish-orange pigment called prodigiosin. This organism's virulence in the cornea stems in part from its production of proteases and bacterial endotoxins. [4] It mainly infects the respiratory and urinary tracts and is responsible as well for 2% of nosocomial infections. [5] The reservoir of S. marcescens is usually the urinary tract, throat and nose and mode of spread is hand-to-hand transmission. [1],[3]
Serratia infections in neonates are frequent (11-15% in neonatal intensive care unit) and may include bloodstream infection (42%), conjunctivitis (26%), pneumonia (13%), urinary tract infection (8%), meningitis (7%) and surgical site infections. [1],[6]
Nasolacrimal duct (NLD) obstruction, whether congenital or acquired, predisposes lacrimal drainage system (LDS) to secondary bacterial infection due to stagnation of the tear within the lacrimal sac (LS). Congenital nasolacrimal duct obstruction (CNLDO) has been reported in up to 6% of newborn infants. [5] The lacrimal ducts are not patent in 20% of full term neonates; additionally, nonpatent lacrimal ducts allow bacteria, tears and other debris to pool on the surface of the eye and provide a medium for bacterial growth. [3] A functional lacrimal system produces tear components, opening and closing of the eyelids act as a pump to facilitate tear distribution across the surface of the eye and the lacrimal ducts act as a drainage system that carries away tears, epithelial debris and bacteria.
Here, the NLD obstruction would have attributed to the infection along with an immunocompromised state of the infant, as evidenced by repeated and prolonged urinary tract infection not responding to treatment in the early stages.
Frequent LS massage and topical antibiotics are considered a conservative method of treatment that is most effective during the first year of life. Otherwise, surgical probing or silastic intubation is performed to overcome the unresolved obstruction. Different microorganisms were correlated with the severity of NLD obstruction observed during surgical intervention. The success rates of probing and silastic intubation as a primary procedure for each identifiable microorganism were documented. Infections due to S. marcescens and Staphylococcus aureus were more prevalent in cases of tight CNLDO. S. marcescens infections had 100% successful silastic intubation. Identification of the pathogen may be used to predict tight CNLDO and helps in choosing the most successful treatment option. In a study done in Saudi Arabia, CNLDO with Staphylococcus infection and S. marcescens were more likely to have tight NLD obstruction and silastic intubation had better outcomes. [5] Isolation and identification of S. marcescens is important to start appropriate treatment, especially in neonatal conjunctivitis.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | |
2. | Liu J, Kwon YH. Seton Infection: Serratia Marcescens: 57-Year-Old White Female with 1 day History of Redness, Swelling, and Pain in her Right Eye. Available from: . [Last accessed on 2005 Mar 5]. |
3. | Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J 2005;24:586-9. |
4. | |
5. | Al-Faky YL, Naeem T, Al-Sobaie N, Al-Huthail R, Al-Odan H, Osman EA, et al. Value of microbiology study in congenital nasolacrimal duct obstruction. Saudi J Ophthalmol 2012;26: 223-8. |
6. | Dessi A, Puddu M, Testa M, Marcialis MA, Pintus MC, Fanos V. Serratia marcescens infections and outbreaks in neonatal intensive care units. J Chemother 2009;21:493-9. |
|